What’s new

• Board withdrew the proposed ₹10 cr preferential issue of 8 lakh shares at ₹125 each.
• Previously passed shareholder resolutions for the issue and authorised capital increase are cancelled.
• Company cites 'unavoidable circumstances' but provides no further details.

Why it matters

For a nano-cap with ₹206 cr market value, a ₹10 cr injection was not trivial. The U-turn removes both the capital and the dilution that was priced in. Without a reason, the market is left to guess whether the funding need remains and if so, how it will be met.

What we’re watching

• Any further disclosure explaining the 'unavoidable circumstances'.
• Whether the company revisits fundraising at an 'appropriate time' as hinted.
• Impact on operations or growth plans if the capital was earmarked for specific use.

The full read

Mizzen Ventures has scrapped a ₹10 crore preferential issue approved just weeks ago. The board offered no reason beyond 'unavoidable circumstances'. For a company with a market cap of just ₹206 crore, the planned ₹10 crore infusion was material, roughly 4.85% of its equity value. The cancellation also wipes out the corresponding increase in authorised share capital, with ratification to be sought at the next general meeting. The decision is a reversal from a publicly disclosed plan approved by the Preferential Issue Committee on 18 June 2026. Without a clear explanation, investors are left to wonder whether the funding need persists and, if so, how the company will fill the gap. Trust in execution just took a hit.

Primary source: BSE · NSE